HK1046234B - 環丙砂星(ciprofloxacin)的藥品成分及有關製劑加工 - Google Patents

環丙砂星(ciprofloxacin)的藥品成分及有關製劑加工

Info

Publication number
HK1046234B
HK1046234B HK02105791.8A HK02105791A HK1046234B HK 1046234 B HK1046234 B HK 1046234B HK 02105791 A HK02105791 A HK 02105791A HK 1046234 B HK1046234 B HK 1046234B
Authority
HK
Hong Kong
Prior art keywords
weight
ciprofloxacin
pharmaceutical composition
preparation
containing pharmaceutical
Prior art date
Application number
HK02105791.8A
Other languages
English (en)
Other versions
HK1046234A1 (en
Inventor
Fekete Pal
Fellner Gyorgyne
Gora Laszlone
Jambor Istvanne
Feikus Szilvia
Palfi Zoltanne
Zsigmond Zsolt
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of HK1046234A1 publication Critical patent/HK1046234A1/xx
Publication of HK1046234B publication Critical patent/HK1046234B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK02105791.8A 1999-08-11 2002-08-07 環丙砂星(ciprofloxacin)的藥品成分及有關製劑加工 HK1046234B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9902725A HU227070B1 (en) 1999-08-11 1999-08-11 Immediate release pharmaceutical composition containing ciprofloxacin and process for its production
PCT/HU2000/000090 WO2001012162A1 (en) 1999-08-11 2000-08-11 Ciprofloxacin containing pharmaceutical composition and process for the preparation thereof

Publications (2)

Publication Number Publication Date
HK1046234A1 HK1046234A1 (en) 2003-01-03
HK1046234B true HK1046234B (zh) 2004-03-19

Family

ID=89999030

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105791.8A HK1046234B (zh) 1999-08-11 2002-08-07 環丙砂星(ciprofloxacin)的藥品成分及有關製劑加工

Country Status (13)

Country Link
EP (1) EP1207857B1 (zh)
AT (1) ATE241967T1 (zh)
AU (1) AU6716100A (zh)
BG (1) BG106404A (zh)
CZ (1) CZ2002505A3 (zh)
DE (1) DE60003196T2 (zh)
HK (1) HK1046234B (zh)
HU (1) HU227070B1 (zh)
PL (1) PL352331A1 (zh)
RU (1) RU2251420C2 (zh)
SK (1) SK285236B6 (zh)
UA (1) UA72270C2 (zh)
WO (1) WO2001012162A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
WO2005021000A1 (en) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Solid oral dosage forms of gatifloxacin
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
EP1880722B1 (en) * 2006-07-19 2010-03-17 Tabuk Pharmaceutical Manufacturing Co. Pharmaceutical compositions of ciprofloxacin
CN107669645A (zh) * 2017-10-31 2018-02-09 瑞阳制药有限公司 盐酸环丙沙星片的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
EP0918513B1 (de) * 1996-08-15 2000-12-06 Losan Pharma GmbH Gut schluckbare orale arzneiform

Also Published As

Publication number Publication date
CZ2002505A3 (cs) 2002-06-12
PL352331A1 (en) 2003-08-11
DE60003196D1 (de) 2003-07-10
HK1046234A1 (en) 2003-01-03
WO2001012162A1 (en) 2001-02-22
UA72270C2 (en) 2005-02-15
SK285236B6 (sk) 2006-09-07
RU2251420C2 (ru) 2005-05-10
HU9902725D0 (en) 1999-10-28
SK2132002A3 (en) 2002-08-06
EP1207857A1 (en) 2002-05-29
BG106404A (en) 2002-09-30
DE60003196T2 (de) 2004-04-29
EP1207857B1 (en) 2003-06-04
RU2002106727A (ru) 2004-01-10
HU227070B1 (en) 2010-06-28
ATE241967T1 (de) 2003-06-15
AU6716100A (en) 2001-03-13
HUP9902725A2 (hu) 2001-12-28

Similar Documents

Publication Publication Date Title
WO2007048219A3 (en) Sustained drug release composition
CA2367136A1 (en) Use of xenon for treating neurointoxications
WO2006123357A3 (en) Oral controlled release composition containing levetiracetam
PE20010982A1 (es) Composicion estable para dosis oral de liberacion extendida
MY122392A (en) Adamantane derivatives of use of p2x7 receptor antagonists, a process for their preparation, pharmaceutical compositions containing them and a process for preparing the pharmaceutical compositions
BR9810984A (pt) Composto de triazol, uso do mesmo, e, composição farmacêutica
IL125848A0 (en) New compositions containing copidogrel and an antithrombotic agent
HUP0003691A2 (hu) Gyorsan széteső, többrészes tabletták
DZ2549A1 (fr) Compositions pharmaceutiques contenant de l'hémisulfate d'élétriptan.
SI0948320T1 (en) PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF THE HMG-CoA REDUCTASE INHIBITOR FLUVASTATIN
TR200301723T4 (tr) 1,3 Dihidro-2H-indol-2 one türevleri ve bunların, arginin-vasopressin' in V1B veya V1B reseptörleri için bağ maddeleri olarak kullanımı
CA2325739A1 (en) Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator
WO2007021968A3 (en) Sustained release antihistamine and decongestant composition
BR0207872A (pt) Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração
CA2378428A1 (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
IL141236A0 (en) New oral formulations for 5-ht4 agonists or antagonists
HK1046234A1 (en) Ciprofloxacin containing pharmaceutical composition and process for the preparation thereof
AP1485A (en) Orally administered controlled delivery system for once daily administration of ciprofloxacin.
NZ523606A (en) Pharmaceutical compositions and methods for use
AR021158A2 (es) Composiciones orales de 8-cloro-6,11-dihidro-11-(4-piperidilidin)-5h-benzo[5,6]-ciclohepta[1,2-b]piridina
WO2002011740A3 (en) 'slow release' pharmaceutical compositions comprising lithium carbonate
WO2002004012A8 (en) Anhydrous pharmaceutical composition of vancomycin for topical use
MXPA03008061A (es) Composiciones desodorantes y antitranspirantes anhidras que contienen un agente dermoactivo solido soluble en agua y glicerina.
EP1144010A3 (en) Methods of prolonging transplant survival using immunotoxins and costimulation blockade of cd154 and cd28
MX2024001034A (es) Composicion farmaceutica multiparticulada.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20070811